Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Metlife Inc. buy Wells Fargo & Company

Start price
€61.33
06.02.24 / 50%
Target price
€77.17
06.02.25
Performance (%)
7.32%
Price
€65.82
26.04.24
Summary
This prediction is currently active. The BUY prediction by Wells_Fargo___Compan shows slight gains of 7.32%. This prediction currently runs until 06.02.25. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this prediction

MetLife Inc. (Symbol: MET) (WKN: 934623) is a globally renowned insurance, annuities, and employee benefits company, founded in 1868, with its headquarters in New York City. As a leading player in the financial services sector, this Fortune 500 company offers a comprehensive range of products and services, including life insurance, dental and vision coverage, accident and health insurance, retirement and savings solutions, and more. Boasting a diverse clientele, MetLife serves individual customers, SMEs, and large-scale corporations across the globe, with a strong focus on enhancing value for its shareholders, policyholders, and clients. With an underlying commitment to innovation and customer-centric strategies, this publicly traded company (NYSA: MET) has established its presence in more than 40 countries, continuing to expand its horizons in the changing dynamics of global demographics and financial security needs.

Performance without dividends (%)
Name 1w 1m
Metlife Inc. -1.393% -1.393%
iShares Core DAX® 2.594% -1.158%
iShares Nasdaq 100 3.553% -1.727%
iShares Nikkei 225® 0.687% -8.354%
iShares S&P 500 2.209% -0.942%

Comments by Wells_Fargo___Compan for this prediction

In the thread Metlife Inc. diskutieren
Prediction Buy
Perf. (%) 7.32%
Target price 77.173
Change
Ends at 06.02.25

MetLife, Inc. (NYSE: MET) had its price target lowered by analysts at Wells Fargo & Company from $85.00 to $83.00. They now have an "overweight" rating on the stock.
Ratings data for MET provided by MarketBeat

Stopped prediction by Wells_Fargo___Compan for Metlife Inc.

buy
Metlife Inc.

Start price
Target price
Perf. (%)
€66.09
11.04.24
€80.27
11.04.25
-0.41%
26.04.24

buy
Metlife Inc.

Start price
Target price
Perf. (%)
€56.73
15.08.23
€75.85
15.08.24
17.73%
26.04.24

buy
Metlife Inc.

Start price
Target price
Perf. (%)
€52.84
05.04.23
€65.78
05.04.24
29.54%
06.04.24